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Abstract
Background: Influenza is a common and serious public health problem among the elderly. The
influenza vaccine is safe and effective.
Methods: The purpose of the study was to determine whether frequencies of receipt vary by race,
age group, gender, and time (progress from 1995/1996 to 2000), and whether any racial differences
remain in age groups covered by Medicare. Subjects were selected from the Health and Retirement
Study (HRS) (12,652 Americans 50–61 years of age (1992–2000)) and the Asset and Health
Dynamics Among the Oldest Old (AHEAD) survey (8,124 community-dwelling seniors aged 70+
years (1993–2000)). Using multivariate logistic regression, adjusting for potential confounders, we
estimated the relationship between race, age group, gender, time and the main outcome measure,
receipt of influenza vaccination in the last 2 years.
Results: There has been a clear increase in the unadjusted rates of receipt of influenza vaccination
for all groups from 1995/1996 to 2000. However, the proportions immunized are 10–20% higher
among White than among Black elderly, with no obvious narrowing of the racial gap from 1995/
1996 to 2000. There is an increase in rates from age 50 to age 65. After age 70, the rate appears
to plateau. In multivariate analyses, the racial difference remains after adjusting for a series of
socioeconomic, health, and health care related variables. (HRS: OR = 0.63 (0.55–0.72), AHEAD:
OR = 0.55 (0.44–0.66))
Conclusions: There is much work left if the Healthy People 2010 goal of 90% of the elderly
immunized against influenza annually is to be achieved. Close coordination between public health
programs and clinical prevention efforts in primary care is necessary, but to be truly effective, these
services must be culturally appropriate.
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Influenza frequently causes several days of incapacitating
malaise for otherwise healthy individuals. In the elderly
and persons with chronic medical conditions, it increases
risk for serious complications and death. Twenty to 40
thousand deaths are attributed to influenza each year,
with 90 percent of these in patients over age 65. [1] Influ-
enza also has a large economic impact, in the United
States estimated to exceed $12 billion annually.[2]
Immunization, using inactivated virus, is cheap, safe, and
effective. [3-6] Most clinical guidelines recommend
annual vaccination of the elderly.[1,7] The U.S. Preventive
Services Task Force advises vaccination for anyone over
age 65 as well as for patients with chronic diseases such as
cardiopulmonary disorders, metabolic diseases, and
immuno-suppression.[1] The American College of Pre-
ventive Medicine recommends influenza vaccination for
everyone over the age of 18 for whom it is not
contraindicated.[7]
Since 1993, Medicare has provided Part B coverage for the
influenza vaccine and its administration [8], and
although immunization rates have steadily increased
since then [9], Medicare's specific contribution to this
increase is not clear.
Healthy People 2000 established a goal of 60% immuniza-
tion among elderly aged 65 and above and high risk per-
sons [10], a goal that was surpassed in most states,
especially among Whites. [11] Among non-institutional-
ized high-risk persons 50–64, only 40% received the
influenza vaccine in 1997. Healthy People 2010 set the goal
for influenza vaccination to 90% for persons aged 65 and
above.[12] A recent Institute of Medicine report also tar-
gets increased influenza vaccination as one of 20 key areas
to improve US health care [13], and that special efforts
should be made among African American and Hispanic
adults and nursing home residents.
Earlier studies have shown persistent racial disparities, not
only for influenza morbidity [6], but also for immuniza-
tion coverage. [14,15] In 1998, the influenza vaccination
rate was 46% among non-Hispanic Black elderly.[6]
Under age 65, such racial discrepancy may be due to
health insurance differences, but health insurance differ-
ences should not play a central role after Medicare
becomes available to all groups at age 65.
The objective of these analyses is to evaluate the determi-
nants of influenza vaccination among the elderly, based
on 2 large, national studies of middle aged and old Amer-
icans. We investigate whether the reported frequencies of
receipt vary by age group, gender and race. In addition, we
document whether any racial differences persist in age
groups covered by Medicare insurance, and evaluate the
cohorts' recent progress, from 1996 to 2000, towards the
goals of Healthy People 2010. In multivariate analyses, we
investigate the importance of demographic, socioeco-
nomic, health status and health care factors as predictors
of influenza vaccination.
Methods
Data
Data The Health and Retirement Study (HRS) is a national
cohort study with an initial sample of over 12,600 per-
sons.[16] The survey contains information about health
behaviors, ill health and disability, medical care usage,
and other topics. The baseline survey (1992) was an in-
home, face-to-face interview for the 1931–41 birth cohort
(and their spouses, regardless of age). A question module
relating to receipt of clinical preventive services, including
influenza vaccination, was included in wave 3 (1996) and
wave 5 (2000).
The Asset and Health Dynamics Among the Oldest Old
(AHEAD) database is a companion national panel study
designed to monitor similar topics in an older age
group.[17] The initial sample (wave 1: 1993) consisted of
7,447 respondents aged 70 and over (and their spouses,
regardless of age) who lived in the community. If the sub-
ject was unable to participate in the interview, a proxy
respondent was identified and interviewed in stead. Per-
sons aged 80+ were over-sampled to allow for more pre-
cise estimates in this group. The follow-up interviews were
conducted by telephone (wave 2: 1995; wave 3: 1998;
wave 4: 2000). As in HRS, people of Hispanic origin, Afri-
can-Americans and Florida residents were over-sampled
(100%). The question pertaining to influenza vaccination
was included in wave 2 and wave 4.
Dependent variable
The question measuring influenza vaccination in both
HRS and AHEAD was as follows: "Since we talked to you
last .... [i.e. 2 years ago]" or [if the respondent had not
completed the survey 2 years earlier]: "In the last 2 years,
have you had any of the following medical tests or procedures:"
"A flu shot"? (etc.) Therefore, the annual prevalence of
influenza immunization is unavailable, but a 2-year prev-
alence can be determined, i.e. the proportion of persons
who received an influenza immunization at least once
over that period.
Explanatory variables
Receipt of influenza vaccination reported in 2000 (with
the corresponding independent variables measured in
1998 – please see below) was contrasted with receipt
reported in 1995/1996 (with the independent variables
measured in 1993). Age was grouped in 5-year intervals.
Independent variables included sex, race (White or Black),Page 2 of 10
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Variables HRS*1996 HRS 2000 AHEAD*1995 AHEAD 2000
Female
n = 4375
Male
n = 3676
Female
n = 4859
Male
n = 4030
Female
n = 3840
Male
n = 2386
Female
n = 3049
Male
n = 1526
Demographic
Age 50–54 35 29 43 41
Age 55–59 38 35 52 46
Age 60–64 46 41 58 53
Age 70–74 67 71 77 81
Age 75–79 67 74 75 82
Age 80–84 68 69 76 80
Age 85–89 65 61 76 81
White 41 36 58 58 69 72 77 82
Black 28 32 45 50 51 51 60 68
Socioeconomic
Completed high school 41 37 58 59 71 73 78 82
Not completed high school 36 31 52 53 62 66 71 78
Born in the US 40 36 57 58 68 71 76 81
Born abroad 35 31 47 46 61 61 77 73
Married 42 36 59 59 71 72 80 82
Not married 35 34 52 50 65 66 73 77
Income category a 1 37 36 53 54 61 60 70 69
Income category 2 38 29 58 64 67 68 77 81
Income category 3 42 37 57 57 67 72 76 82
Income category 4 43 38 58 54 76 77 80 84
Health
Smokers 36 30 49 45 57 56 64 70
Non smokers 41 38 58 60 68 72 77 82
Less physical activity 57 57 74 79
Vigorous exercise 57 57 79 83
Health excellent, v. good, good 38 35 55 55 66 70 75 81
Health poor or fair 46 42 60 64 68 71 77 80
Cognitively normal 68 71 77 82
Cognitively impaired 54 56 62 67
Subj. life expectation b 0–33 37 34 60 62 67 71 75 80
Subj. life expectation 34–66 41 39 58 53 68 74 78 83
Subj. life expectation 67–100 40 35 53 52 67 65 75 79
Health Care
Uninsured 30 23 38 27
Insured 41 37 58 59
No additional private insurance 56 57 76 81
Additional private insurance 70 74 64 80
Not in hospital last year 39 34 55 55 66 70 75 79
Hospitalized in the last year 47 46 66 67 71 74 78 84
0–2 doctor visits last year 29 26 43 40 59 61 58 67
3–5 doctor visits last year 38 39 55 60 72 76 75 81
6+ doctor visits last year 49 46 64 67 72 79 80 84
Not admitted to nursing home 67 71 76 81
Admitted to nursing home 67 77
* HRS – Health and Retirement Study AHEAD – Asset and Health Dynamics Among Oldest Old Survey a. Household income categories (in $): HRS 
1996: 1. less than or equal to 13,000 2. 13,001–31,600 3. 31,600–58,269 4. more than 58,269 HRS 2000: 1. less than or equal to 8,295 2. 8,296–
20,420 3. 20,421–49,504 4. more than 49,504 AHEAD 1995: 1. less than or equal to 10,560 2. 10,561–18,000 3. 18,001–30,000 4. more than 30,000 
AHEAD 2000: 1. less than or equal to 8,400 2. 8,401–12,000 3. 12,001–18,840 4. more than 18,840 b. Subjective life expectation: HRS: "(What is 
the percent chance) that you will live to be 75 or more?". AHEAD: "(Using a number from 0 to 100), what do you think are the chances that you 
will live another 5 years?"Page 3 of 10
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high school had been completed. Household income was
categorized into 4 groups (by quartiles for each of the 2
surveys – please see footnote to Table 1).
Current smokers were compared to current non-smokers
and those who reported engaging in vigorous exercise
compared to those who did not report exercising vigor-
ously. Those who reported their health as being fair or
poor were contrasted with those who reported their health
as being excellent, very good or good, and (in AHEAD
only) those with cognitive impairment were contrasted
with those who were cognitively normal [18]. A question
relating to subjective life expectation was also included
(please see footnote to Table 1).
In HRS' pre-Medicare population, subjects without health
insurance were compared to those with any type of health
insurance. In AHEAD, where nearly all subjects were cov-
ered by Medicare, those with additional, private insurance
were compared to those without additional insurance.
Three categories were constructed based on the number of
outpatient physician visits in the last year (0–2, 3–5, 6 or
more) (indicating amount of 'exposure' to the health care
system).
Analysis The weighted proportions of respondents in both
HRS and AHEAD who had received influenza vaccination
since the previous wave were evaluated by race, age group,
sex and wave (1995/1996; 2000). Since no sample
weights were available for the respondents to the year
2000 questionnaires (and for consistency with the multi-
variate analyses: please see below), weights from the previ-
ous wave were utilized (i.e. sample weights from 1993/
1994 were applied to data from 1995/1996; sample
weights from 1998 were applied to data from 2000.)
Analysis
In bivariate analyses, parallel data elements from the 2
surveys were used to relate a set of explanatory factors to
influenza vaccination. To indicate time trends by race, age
group and gender, report of influenza vaccination from
the 1995/1996 and 2000 waves were first estimated.
Available sample weights were used in this analysis.
Beyond simple compensation for unequal selection prob-
abilities, weighting factors were also used to adjust for
geographic and race group differences in response rates in
Wave 1. [19] In subsequent waves, the weights were con-
sistently adjusted for sample attrition and mortality.[20]
Based on those respondents who had completed the influ-
enza question in 1995/1996 or 2000, the weighted pro-
portions who reported receipt were tabulated by category
of the explanatory variables (explanatory variables meas-
ured in the wave preceding the report of receipt).
The respondents who completed the influenza question
in 1995/1996 and/ or 2000 (i.e. the outcome variable)
(HRS 1996: n = 10,754, AHEAD 1995: n = 6,936, HRS
2000: n = 9,606, AHEAD 2000: n = 4,845) were eligible
for the multivariate analyses. Since receipt of influenza
vaccination referred to the interval between the current
and the previous wave ("In the last 2 years..." or "...since
we spoke to you last."), the values of the explanatory var-
iables from the wave preceding the value of the outcome
variable were selected (i.e. predictors 1993/1994 -> out-
come 1995/1996; predictors 1998 -> outcome 2000.)
Using multivariate logistic regression, models were first
developed separately for the 1993/1994–1995/1996
waves and for the 1998–2000 waves (results not shown).
Subsequently, observations for each respondent were
stacked (most respondents provided 2 outcome values
and 2 sets of explanatory values). In the latter models,
because the observations for the same person in different
waves were not independent of one another, clustering of
observations at the individual level was adjusted for by
obtaining Huber-White corrected standard errors. [21,22]
Odds ratios and 95% confidence intervals are reported.
Models were estimated separately for HRS and AHEAD
using very similar variables from both surveys. In addition
to simple models including only year (wave) and demo-
graphic variables, more comprehensive models were also
developed with predictor variables from the following
groups: demographic, socioeconomic, health related,
health care related. In the stacked models, a variable indi-
cating interaction between race and wave was also
included (indicating whether the difference in receipt of
influenza vaccination between the races was increasing or
decreasing from 1995/1996 to 2000).
SAS (version 8.01) was used for the statistical analyses.
This project was approved by the Duke University Medical
Center's Institutional Review Board.
Results
From Figures 1 and 2, it is clear that there has been an
increase in the unadjusted influenza vaccination rates for
both genders and for all age groups from 1995/1996 to
2000, and that this increase has taken place in both Black
and White Americans. There is an increase in rates from
age 50 to age 65, with a plateau in older groups. However,
Black men and women have consistently lower rates than
their white counterparts, with no obvious narrowing of
the racial gap (i.e. steeper slopes for Blacks than for
Whites) from 1995/1996 to 2000 among either gender.
In bivariate analyses (accounting for sample weights),
among persons aged 50–54 in 1995, 35% of females and
29% of males reported receipt of vaccination in the pre-Page 4 of 10
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females and 69% of males who were between the ages of
80 and 84 in 1996 reported receipt, rising to 76% of
females and 80% of males in the same age group by the
year 2000. The proportion of persons reporting immuni-
zation rose for every age group analyzed between 50 and
89 years of age. Several other demographic variables were
related to immunization. Those who had completed high
school had higher rates of immunization compared to
those who did not. Household income was not consist-
ently related to immunization among the HRS sample,
but among the older AHEAD respondents those with
higher incomes were more likely to have received influ-
enza immunization. Married persons were also more
likely to receive immunization compared to those not
married in both databases.
Those who did not smoke were more likely to be immu-
nized, and among older persons those who exercised were
more likely to have received the immunization. Individu-
als' subjective beliefs about their current health as well as
their subjective expected longevity might theoretically
alter patients' receipt of the influenza vaccination. Gener-
ally, persons who reported fair or poor health status were
more likely to report receipt of the influenza vaccination
compared to those who reported that their health was
good or excellent. The unadjusted relationship between
an individual's subjective belief about his or her likeli-
hood of survival was not as clearly linked to influenza
vaccination.
In multivariate analyses (Tables 2 and 3), the major find-
ings of racial disparity in rates of immunization and
increasing rates over time persisted, both in simple mod-
els controlling for demographic factors, as well as in more
Percentage immunized against influenza by age and year; weighted dataFigure 1
Percentage immunized against influenza by age and year; weighted data. (FEMALES)
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tial confounding factors, including demographics, health
insurance, individual perceptions of health and longevity,
socioeconomic status, health and utilization of health
care services. The increase from 1995/1996 to 2000 net of
the potential confounding variables is significant in all
models. The general finding that Blacks have significantly
lower rates than Whites is also robust, and found in all our
model specifications. The interaction term of race and
year was not significant, indicating that the relative odds
of vaccination among Blacks relative to Whites did not
change during the period, i.e. the rate of change in the
increase did not vary significantly between Blacks and
Whites. The odds of vaccination among Blacks, relative to
Whites, were even lower in AHEAD than in HRS, and
these odds do not appear to be reduced after including the
potential confounding variables, this in spite of the fact
that virtually all persons in AHEAD had Medicare
coverage. Furthermore, interaction with the health care
system generally, as measured by physician visits and hos-
pitalizations, also increased the likelihood of
immunization.
The effect of other demographic factors mirrored the
bivariate results. There are significant increases by age
group in HRS with higher rates of immunization as peo-
ple age, but in AHEAD, the effect of age differed across
models, and the general finding was that age did not have
a large effect within this group. Males and females have
similar rates in HRS, but in AHEAD males have higher
rates. Completing higher education, being born in the
USA and being married remain significantly associated
with higher rates of immunization in all models. House-
hold income is not a significant predictor in the HRS sam-
ple, but is in the AHEAD models – those with lower
incomes being less likely to be immunized.
Percentage immunized against influenza by age and year; weighted dataFigure 2
Percentage immunized against influenza by age and year; weighted data. (MALES)
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most likely to receive the influenza immunization. Smok-
ers were less likely, while persons reporting a higher level
of physical activity were more likely to have been immu-
nized. Conversely, persons with more positive subjective
views of their current health and their future longevity
were less likely to receive immunization. Those reporting
fair or poor health had a higher rate of receipt, suggesting
that those who view themselves as healthy do not perceive
a strong risk reduction benefit of being immunized. Fur-
thermore, persons with a higher value of their subjective
life expectation (which approximates a probability of sur-
vival to age 75 in HRS; and for 10 more years in AHEAD)
were less likely to be immunized in HRS, but there was no
significant effect in AHEAD. Elderly with cognitive
impairment (AHEAD only) were much less likely to have
received an influenza vaccination than those with normal
cognition.
Discussion
Two overall trends stand out when considering rates of
influenza immunization among persons over age 50 in
the United States. The proportion of persons who are
immunized has risen since the mid 1990's. However, per-
sistent disparities in the immunization rates between
Blacks and Whites remain, with Whites having higher
rates regardless of age group or year of survey. These gen-
eral findings are remarkably robust, particularly the racial
difference, even with the addition of many potential con-
founding variables. Despite increasing rates of influenza
immunization, more work must to be done to reach the
Healthy People 2010 goal of 90% immunization annually
since the proportion of persons immunized over a 2-year
period is never higher than 80% among Whites in any age
group, and peaks among Blacks at less than 70%.
Possible reasons for the increase in influenza vaccination
levels among elderly over age 65 years include greater
acceptance of preventive medical services by practitioners
and patients, increased delivery and administration of
vaccination, and new information regarding influenza
vaccine cost-effectiveness and safety.[23,24] Continued
monitoring is needed to determine if vaccination coverage
among persons over age 65 years has plateaued. It is clear
Table 2: Adjusted relative odds of influenza immunization: HRS: multivariate models
Variables Simple Model Comprehensive Model
OR (95% CI) OR (95% CI)
Demographic
Year 2000 a 2.04 (1.92, 2.17) 1.86 (1.74, 1.99)
Age 55–59.9 b 0.79 (0.74, 0.85) 0.86 (0.80, 0.93)
Age 60–64.9 b 0.99 (0.93, 1.07) 1.07 (0.99, 1.15)
Male c 1.06 (1.00, 1.12) 1.03 (0.96, 1.10)
Black d 0.65 (0.58, 0.73) 0.63 (0.55, 0.72)
Black * year 2000 1.02 (0.87, 1.20) 1.01 (0.85, 1.20)
Socioeconomic
Completed high school e 1.23 (1.14, 1.33)
Born in the US f 1.52 (1.36, 1.69)
Married g 1.13 (1.04, 1.22)
Income category 1 h 1.02 (0.93, 1.13)
Income category 2 h 1.06 (0.97, 1.16)
Income category 3 h 1.00 (0.92, 1.09)
Health
Smoking i 0.73 (0.67, 0.78)
Vigorous exercise j 1.09 (1.03, 1.16)
Poor or fair health k 1.25 (1.15, 1.36)
Subj. life expectation 34–66l 0.87 (0.79, 0.94)
Subj. life expectation 67–100l 0.80 (0.74, 0.87)
Health Care
Uninsured m 0.56 (0.50, 0.63)
In hospital in last year n 1.35 (1.23, 1.47)
3–5 doctor visits in the last year o 1.66 (1.53, 1.80)
6+ doctor visits in the last year o 2.31 (2.13, 2.49)
Reference categories: a. Year 1996. b. Age 50–54.9 c. Female d. White e. Not completed high school f. Born abroad g. Not married h. (Household) 
income category 4 (see details in footnote to table 1) i. Not smoking j. Less physical activity k. Excellent, very good or good health l. Subjective life 
expectation 0–33 (see details in footnote to table 1) m. Some health insurance n. Not in hospital last year o. 0–2 doctor visits last yearPage 7 of 10
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tor of influenza immunization, is not a panacea that can
lead to the near-universal level of immunization called for
in Healthy People 2010. It is notable that racial disparities
are larger in our study among persons over age 65, virtu-
ally all of whom have Medicare coverage.
Our findings concur with earlier work which showed that
Blacks are less likely to receive influenza immunization
compared to Whites, even after controlling for health and
certain socioeconomic variables. [6,25] Furthermore,
racial disparities in receipt of health care services in gen-
eral are common in the United States, and this is a priority
area for public health. In 1998, the influenza vaccination
rate among persons over age 65 was 66% among non-His-
panic Whites, 46% among non-Hispanic Blacks, and 50%
among Hispanics. [11] In a study from Louisiana, the rate
for Medicare African American beneficiaries was approxi-
mately one-half that of Caucasian beneficiaries.[15] There
are likely a set of reasons for the differences in immuniza-
tion by race that were not measured in our study. These
reasons may be cultural and/or are related to attributes of
the health beliefs as represented in the Health Belief
Model. [26] For example, past work has found that in
addition to limited knowledge about the disease and the
vaccine [27], in a low-income urban population, concern
about undisclosed vaccine contents exists and appears to
impede acceptance of influenza immunization among
both African-Americans and Caucasians.[28] Misconcep-
tions of the vaccine may even be common among health
care providers, and it is possible that African Americans
are offered the vaccine less. [29] Although shortages of
influenza vaccine have been reported during the 2000–
2001 influenza season [30], it is unlikely that this would
lead to differential use among African Americans and
Caucasians.
Table 3: Adjusted relative odds of influenza immunization: AHEAD: multivariate models
Variables Simple Model Comprehensive Model
OR (95% CI) OR (95% CI)
Demographic
Year 2000 a 1.62 (1.47, 1.77) 1.70 (1.45, 2.00)
Age 75–79.9 b 1.05 (0.95, 1.16) 1.09 (0.97, 1.22)
Age 80–84.9 b 1.03 (0.92, 1.15) 1.09 (0.96, 1.25)
Age 85–89.9 b 0.96 (0.83, 1.11) 1.13 (0.94, 1.35)
Male c 1.22 (1.12, 1.33) 1.16 (1.04, 1.29)
Black d 0.44 (0.38, 0.50) 0.55 (0.45, 0.66)
Black * year 2000 1.08 (0.86, 1.36) 0.97 (0.74, 1.27)
Socioeconomic
Completed high school e 1.19 (1.07, 1.32)
Born in the US f 1.21 (1.03, 1.43)
Married g 1.15 (1.04, 1.28)
Income category 1 h 0.68 (0.59, 0.79)
Income category 2 h 0.79 (0.69, 0.90)
Income category 3 h 0.79 (0.69, 0.90)
Health
Smoking i 0.62 (0.53, 0.72)
Vigorous exercise j 1.20 (1.08, 1.33)
Poor or fair health k 1.07 (0.96, 1.19)
Cognitive impairment l 0.71 (0.60, 0.84)
Subjective life expectation 34–66 m 1.08 (0.96, 1.21)
Subjective life expectation 67–100m 0.92 (0.82, 1.03)
Health Care
Other private insurance n 1.48 (1.28, 1.72)
In hospital in last year o 1.08 (0.96, 1.22)
3–5 doctor visits in the last year p 1.81 (1.61, 2.04)
6+ doctor visits in the last year p 2.15 (1.90, 2.43)
Admitted to nursing home q 1.52 (1.19, 1.94)
Reference categories: a. Year 1995 b. Age 70–74.9 c. Female d. White e. Not completed high school f. Born abroad g. Not married h. Income 
category 4 (see details in footnote to table 1) i. Not smoking j. Less physical activity k. Excellent, very good or good health l. cognitively normal m. 
Subjective life expectation 0–33 (see details in footnote to table 1) n. No other private insurance o. Not in hospital last year p. 0–2 doctor visits last 
year q. Not admitted to nursing home last yearPage 8 of 10
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sentative sample, over-sampling of Black Americans, long-
term follow-up of individuals with information on risk
factors as well as immunization status at more than one
point in time. The overall rates of immunization are
broadly consistent with other national surveys of immu-
nization rates.[6,14] However, since the wording of the
questionnaires refers to the period "within the last two
years", the proportions reporting having been immu-
nized, as reported in Table 1, are higher than annual rates.
Since it is possible that individuals might have been
immunized one or more times in the last two years, we
cannot simply divide the reported rates by two to get the
annual rates, i.e. the corresponding annual rates lie some-
where between our reported rates and half of these rates.
Although the information about influenza vaccination is
based on self-report, similar questions relating to influ-
enza vaccination have been validated.[31] A limitation of
the study is the lack of measures related to detailed health
beliefs and cultural views about medical and preventive
services in HRS and AHEAD, factors which likely pose
persistent barriers to achieving the Healthy People 2010
goals. It would also be interesting to investigate whether
African Americans are offered the vaccine less frequently
or less convincingly.
Influenza was chosen as an indicator for Healthy People
2010 because of its high incidence and serious health and
economic consequences. [32] Few, if any, other preven-
tive or therapeutic interventions for adults match or
exceed the clear benefits of influenza immunization.[2]
Interventions raised immunization rates even before
Medicare covered influenza immunization [33], and sim-
ple systems such as annual mailings, computerized
reminders in the doctor's office [34] and standing orders
for nurses, and pre-printed documentation. [35,36]
increase vaccination rates. However, identifying and
addressing cultural and health belief barriers, and possi-
bly also subtle provider behavior, effectively, are likely key
to developing interventions that are effective in increasing
influenza immunization further.
To successfully develop and implement influenza vaccina-
tion strategies to reach the Healthy People 2010 national
objective of 90% influenza vaccination among the elderly,
additional resources will be needed. Close coordination
between public health programs and clinical prevention
in managed and primary care is necessary, but to be truly
effective, these services must be culturally appropriate.
Conclusion
The proportion of Americans who are immunized against
influenza has risen since the mid 1990's. However, per-
sistent disparities in the immunization rates between
Blacks and Whites remain, with Whites having higher
rates regardless of age group or year of survey. These gen-
eral findings are remarkably robust, particularly the racial
difference, even with the addition of a series of potential
confounding variables.
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